Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Institut Pasteur › Matthew Albert
MA

Matthew Albert — 13 Patents

IPInstitut Pasteur: 7 patents #88 of 1,210Top 8%
TUThe Rockefeller University: 4 patents #105 of 698Top 20%
I(Institut National De La Sante Et De La Recherche Medicale (Inserm): 3 patents #219 of 2,676Top 9%
Genentech: 2 patents #1,171 of 2,392Top 50%
A(Assistance Publique—Hôpitaux De Paris (Aphp): 1 patents #300 of 877Top 35%
Overall (All Time): #362,438 of 4,157,543Top 9%
13 Patents All Time
Matthew Albert has been granted 13 US patents while listed as an inventor at Institut Pasteur. The first was granted in 2003 and the most recent in December 2024. Matthew Albert ranks #362,438 of 4,157,543 US inventors in our database (top 8.7%). Patent records list Matthew Albert in Paris, NY, FR.

Issued Patents All Time

Showing 1–13 of 13 patents

Patent #TitleCo-InventorsDate
12183434 Diagnostic and therapeutic methods for cancer Zia Khan, G Scott CHANDLER 2024-12-31
11883398 Dipeptidylpeptidase 4 inhibition enhances lymphocyte trafficking, improving both naturally occurring tumor immunity and immunotherapy Rosa BARREIRA DA SILVA 2024-01-30
11739150 Anti-CD8 antibodies and uses thereof Yvonne Chen, Eugene Yu-Chuan CHIANG, Jane L. GROGAN, Simon Williams 2023-08-29
11229645 Dipeptidylpeptidase 4 inhibition enhances lymphocyte trafficking, improving both naturally occurring tumor immunity and immunotherapy Rosa BARREIRA DA SILVA 2022-01-25
11000521 Dipeptidylpeptidase 4 inhibition enhances lymphocyte trafficking, improving both naturally occurring tumor immunity and immunotherapy Rosa BARREIRA DA SILVA 2021-05-11
10254282 Levels of CXCL10/IP-10 forms and soluble CD26/DPPIV activity as early predictive biomarkers for HIV/SIV associated mucosal inflammation and progression towards AIDS Michaela Muller-Trutwin, Mickaël J. Y. Ploquin, Yoann Madec, Cécile Goujard, Laurence Meyer 2019-04-09
9523687 Levels of CXCL 10/IP-10 forms and soluble CD26/DPPIV activity as early predictive biomarkers for HIV/SIV associated mucosal inflammation and progression towards AIDS Michaela Muller-Trutwin, Mickaël J. Y. Ploquin, Yoann Madec, Cécile Goujard, Laurence Meyer 2016-12-20
8124332 Methods of using sIP-10, CD26 inhibitors and CXCR3 levels in a sample to assess clearance of infection, response to interferon therapy, and treating chronic infections Armanda Casrouge, Jeremie Decalf, Stanislas Pol, Arnaud Fontanet, Mostafa Mohamed 2012-02-28
7989203 Methods for use of apoptotic cells to deliver antigen to dendritic cells for induction or tolerization of T cells Nina Bhardwaj, Ralph M. Steinman, Kayo Inaba, Robert B. Darnell 2011-08-02
7674578 Methods of using sIP-10 to assess HCV clearance and/or response to interferon therapy Jeremie Decalf, Stanislas Pol, Arnaud Fontanet, Mostafa Mohamed 2010-03-09
7129037 Methods for use of apoptotic cells to deliver antigen to dendritic cells for induction or tolerization of T cells Nina Bhardwaj, Ralph M. Steinman, Kayo Inaba, Robert B. Darnell 2006-10-31
6750029 Methods and agents for the detection and modulation of cellular immunity to immune privileged antigens Robert B. Darnell, Nina Bhardwai 2004-06-15
6602709 Methods for use of apoptotic cells to deliver antigen to dendritic cells for induction or tolerization of T cells Nina Bhardwaj, Ralph M. Steinman, Kayo Inaba, Robert B. Darnell 2003-08-05

Nearby-Ranked Inventors

Jianping Shen13
Eric John Telfeyan13
George R. Breiwa, III13
Thomas Sugar13
Andrew Howley13
Howard Halpern13
Po-Yuan Wang13
Douglas Vanesko13
Tanuj Trivedi13